The 20 Best Chromophobe Renal Cell Carcinoma Doctors Near Me in San Francisco, CA

Eric Miller is a Urologist practicing medicine in San Francisco, California. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant. Dr. Miller is currently accepting new patients.

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Meng is board certified in American Board Of Urology, Urology. Dr. Meng is currently accepting new patients.

Dr. Arpita Desai is a medical oncologist who specializes in caring for patients with genitourinary cancers (cancers of the genital or urinary organs). She particularly focuses on kidney and prostate cancers. She serves as medical director of the genitourinary medical oncology program at UCSF, where she leads efforts to deliver multidisciplinary, patient-centered care and advance innovative treatments. She also leads the UCSF kidney cancer program, which brings together clinical care, translational research and innovation to improve outcomes for patients with renal cell carcinoma. She also serves as medical director of the UCSF Von Hippel–Lindau multidisciplinary clinic, which integrates oncology, genetics, nephrology, ophthalmology, neurosurgery, endocrinology and other specialties to provide comprehensive, coordinated care for patients with Von-Hippel Lindau disease (a rare genetic disorder that increases a patient's risk of tumors). Through her leadership, research and national collaborations, Desai is committed to advancing precision medicine in kidney cancer and improving the lives of patients through both cutting-edge clinical care and translational research (lab findings that can lead to improvements in real-world patient care). In research, Desai is interested in developing novel imaging and treatment strategies for renal cell carcinoma, the most common type of kidney cancer. She is particularly interested in integrating functional and molecular imaging to personalize treatment and improve patient outcomes. Her research program examines theranostics, hyperpolarized MRI and biomarker-driven approaches to optimize treatments for genitourinary cancers. Desai earned her medical degree at Rajiv Gandhi University of Health Sciences in India. She completed a residency in internal medicine at the State University of New York at Buffalo, where she served as chief resident. She completed a fellowship in medical oncology at the University of Chicago. Desai is an active member of the American Society of Clinical Oncology (ASCO) and American Association for Cancer Research and the National Comprehensive Cancer Network (NCCN) Kidney Cancer Guidelines Panel. She has received a Cancer Research Institute Investigator’s Technology Impact Award, Conquer Cancer Foundation of ASCO Merit Award and Dexter S. Levy, MD, Memorial Award for her commitment to teaching and excellence in patient care and has also been recognized with several awards for her mentorship and research. Dr. Desai is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Clear Cell Sarcoma, and Wilms Tumor. Dr. Desai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Desai is currently accepting new patients.

Won Kim is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Cardiac Ablation, and Angioplasty.

Mikhail Regelman is a Urologist practicing medicine in San Francisco, California. Dr. Regelman is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses UPJ Obstruction, Enlarged Prostate (BPH), Urothelial Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Regelman is board certified in Urology. Dr. Regelman is currently accepting new patients.

Brian Grady is a Urologist practicing medicine in San Francisco, California. Dr. Grady is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Prostatectomy. Dr. Grady is board certified in Urology - Board Certified. Dr. Grady is currently accepting new patients.

Stephanie Jeske is an Oncologist practicing medicine in San Francisco, California. Dr. Jeske is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Jeske is currently accepting new patients.

Gauri Kelekar is an Oncologist practicing medicine in San Francisco, California. She has been practicing medicine for over 18 years. Dr. Kelekar is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Hemochromatosis, Familial Colorectal Cancer, and Urothelial Cancer. Dr. Kelekar is board certified in Medical Oncology - Internal Medicine Hematology. Dr. Kelekar is currently accepting new patients.

Caring, compassionate, and patient centric care. Dr. Quock is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Quock is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Quock is currently accepting new patients.

Terence Friedlander is a Hematologist practicing medicine in San Francisco, California. Dr. Friedlander is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Prostatectomy.

Ira Sharlip is a Urologist practicing medicine in San Francisco, California. Dr. Sharlip is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Premature Ejaculation, Enlarged Prostate (BPH), Urinary Tract Infection in Children, Prostatectomy, and Vasectomy. Dr. Sharlip is board certified in American Board Of Urology, Urology and American Board Of Internal Medicine, Internal Medicine. Dr. Sharlip is currently accepting new patients.

Donald Abrams is an Oncologist practicing medicine in San Francisco, California. Dr. Abrams is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Familial Prostate Cancer.

Wenwu Jin is a Urologist practicing medicine in San Francisco, California. Dr. Jin is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Boils, Kidney Stones, Reconstructive Urology Surgery, and Ureteroscopy. Dr. Jin is board certified in Urology. Dr. Jin is currently accepting new patients.

Raul Hernandez is a Urologist practicing medicine in San Francisco, California. Dr. Hernandez is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), UPJ Obstruction, Orchitis, Prostatectomy, and Ureteroscopy.

Dr. Rahul Aggarwal is a specialist in cancers of the genital and urinary organs. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men who are receiving androgen deprivation therapy, hormone therapy for prostate cancer. As a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early-phase clinical trials of novel targeted treatments. His research focuses on developing hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. He is also interested in developing new molecular imaging techniques that will help predict how advanced solid tumors will respond to treatment. Aggarwal earned his medical degree from the Northwestern University Feinberg School of Medicine. At UCSF, he completed an internship and residency in internal medicine, followed by a clinical fellowship in hematology and oncology. Aggarwal has also been a research fellow in developmental therapeutics at Genentech. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award. Dr. Aggarwal is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Melanoma of the Eye, and Muscle Invasive Bladder Cancer. Dr. Aggarwal is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Aggarwal is currently accepting new patients.

Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are. In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network. A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time. Dr. Koshkin is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Non-Muscle Invasive Bladder Cancer, and Lymphadenectomy. Dr. Koshkin is board certified in American Board Of Internal Medicine, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Koshkin is currently accepting new patients.

Dr. Hala Borno is a medical oncologist who cares for patients who have cancers along the urinary tract, including kidney, bladder, testicular and prostate cancer. She specializes in treating prostate cancer. Borno's research focuses on improving access to cancer clinical trials and digital health innovation. Borno earned her medical degree from the University of North Carolina at Chapel Hill School of Medicine. She completed a residency in internal medicine and a fellowship in medical oncology at UCSF, where she was selected chief oncology fellow. She is a member of the American Society of Clinical Oncology and Alliance for Clinical Trials in Oncology. Dr. Borno is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and Orchiectomy. Dr. Borno is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Borno is currently accepting new patients.

Robert Kahn is a Urologist practicing medicine in San Francisco, California. Dr. Kahn is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Wilms Tumor, Familial Wilms Tumor 2, Clear Cell Sarcoma, Reconstructive Urology Surgery, and Nephrectomy.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Greenberg is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Greenberg is board certified in Internal Medicine. Dr. Greenberg is currently accepting new patients.

Dr. Chia-Ching Wang, who goes by Jackie, is an oncologist who treats anal cancer. She also provides cancer screenings with high-resolution anoscopy (an examination using an instrument that can be inserted into the anal canal). Wang's work in research focuses on HIV oncology, particularly HPV-related cancers. (HIV-infected individuals may be at higher risk for developing HPV-related cancers due to their immunosuppression. She hopes to develop and implement prevention strategies, as well as test novel therapies that may improve outcomes for patients with these cancers.) She has also completed studies on lymphoma and Kaposi's sarcoma. She has special interests in superficially invasive squamous cell carcinoma of the anus and in post-treatment surveillance. Wang received her medical degree from the State University of New York at Stony Brook. She began a residency in obstetrics and gynecology at Women & Infants Hospital of Rhode Island, but after the first year, she decided to change her focus to HIV-related work. She subsequently completed a research fellowship at the Miriam Hospital, a teaching affiliate of the Warren Alpert Medical School of Brown University. She then completed a residency in internal medicine at Brown University. After working for a year as a hospitalist (a physician dedicated to patient care in the hospital setting), she came to UCSF for a fellowship in hematology and oncology. Wang is a member of the American Society of Hematology, American Society of Clinical Oncology and American Medical Association. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Lung Cancer. Dr. Wang is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine/Hematology, Hematology. Dr. Wang is currently accepting new patients.